• Explore /
  • Poster
  • / Prognostic value of plasma circulating tumor (ct) DNA <i>KRAS</i> mutations and serum CA19-9 in unresectable pancreatic cancer (PC) patients.

Prognostic value of plasma circulating tumor (ct) DNA KRAS mutations and serum CA19-9 in unresectable pancreatic cancer (PC) patients.

Abstract Poster

Authors

null

Julia S. Johansen

Department of Oncology, Herlev Hospital, Herlev, Denmark

Julia S. Johansen , Cecile Rose T. Vibat , Saege Hancock , Inna Markovna Chen , Latifa Hassaine , Errin Samuelsz , Eric Andrew Collisson , Benny Vittrup Jensen , Timothy T. Lu , Vlada Melnikova , Mark G. Erlander

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Citation

J Clin Oncol 33, 2015 (suppl; abstr 4022)

DOI

10.1200/jco.2015.33.15_suppl.4022

Abstract #

4022

Poster Bd #

131

Abstract Disclosures

Similar Posters

Poster

2015 Gastrointestinal Cancers Symposium

Comparative circulating tumor DNA levels for <i>KRAS</i> mutations in patients with nonresectable pancreatic cancer.

Comparative circulating tumor DNA levels for KRAS mutations in patients with nonresectable pancreatic cancer.

First Author: Julia S. Johansen

First Author: Amit Jethanandani

First Author: Anna M. Varghese

First Author: Hannah Marie Cherniawsky